Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    HPP854
Show Display Options
Rank Status Study
1 Terminated Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
Conditions: Mild Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Drug: HPP854;   Drug: Placebo

Indicates status has not been verified in more than two years